A biotech company is trialling a cannabis compound that it claims will provide insomniacs the rest they need. Around 500 patients in Melbourne, Sydney Brisbane and Perth are currently testing the capsules.
Breakdown
- Synthetic CBD capsules are being trialled as a treatment for insomnia. 4s
- Around 30% of Australian adults experience sleep problems, with nearly half potentially having clinical insomnia. 20s
- Over 500 patients in major Australian cities are participating in the double-blind, randomized trial by Aveco. 40s
- The medication does not contain THC and aims to avoid next-day drowsiness. 1m 13s
- The trial's outcome will determine if the medication can be approved for over-the-counter use. 1m 5s